Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.21B |
| Enterprise Value | 7.53B |
| P/E Ratio | 61.59 |
| PEG Ratio | -1.28 |
| Price/Sales Ratio | 8.58 |
| Price/Book Ratio | 2.86 |
| Enterprise/Revenue | 7.87 |
| Enterprise/EBITDA | 40.33 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 786.77M |
| Revenue/Share | 0.96 |
| Gross Profit | 399.13M |
| EBITDA | 220.47M |
| Net Income | 130.57M |
| Diluted EPS | 0.16 |
Balance Sheet
| Total Cash | 1.15B |
| Total Cash/Share | 1.4 |
| Total Debt | 586.98M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 2.64 |
| Book Value Per Share | 2.87 |
Price History
| 52-Week Change | -5.2 |
| 52-Week High | 12.51 |
| 52-Week Low | 7.63 |
| Moving Average 50 Days | 9.7 |
| Moving Average 200 Days | 9.87 |
Statistics
| Average Volume | 11.72M |
| Shares Outstanding | 830.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 1.22 |
| Payout Ratio | 0.81 |
| Last Split Factor | 7:5 |
| Last Split Date | July 12, 2024 |
AD
